GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (XSWX:ACHI) » Definitions » EBIT

Achiko AG (XSWX:ACHI) EBIT : CHF-5.41 Mil (TTM As of Jun. 2022)


View and export this data going back to 2019. Start your Free Trial

What is Achiko AG EBIT?

Achiko AG's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2022 was CHF-1.92 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2022 was CHF-5.41 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Achiko AG's annualized ROC % for the quarter that ended in Jun. 2022 was -131.20%. Achiko AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2022 was -13,030.51%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Achiko AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2022 was -145.64%.


Achiko AG EBIT Historical Data

The historical data trend for Achiko AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG EBIT Chart

Achiko AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21
EBIT
- -6.56 -12.61 -7.78

Achiko AG Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
EBIT Get a 7-Day Free Trial -4.80 -8.13 -4.23 -3.48 -1.92

Competitive Comparison of Achiko AG's EBIT

For the Health Information Services subindustry, Achiko AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Achiko AG's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Achiko AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Achiko AG's EV-to-EBIT falls into.



Achiko AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-5.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Achiko AG  (XSWX:ACHI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Achiko AG's annualized ROC % for the quarter that ended in Jun. 2022 is calculated as:

ROC % (Q: Jun. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2021 ) + Invested Capital (Q: Jun. 2022 ))/ count )
=-3.726 * ( 1 - 0% )/( (2.023 + 3.657)/ 2 )
=-3.726/2.84
=-131.20 %

where

Note: The Operating Income data used here is two times the semi-annual (Jun. 2022) data.

2. Joel Greenblatt's definition of Return on Capital:

Achiko AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2022 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2022 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2021  Q: Jun. 2022
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-3.844/( ( (0.032 + max(-2.649, 0)) + (0.027 + max(-3.859, 0)) )/ 2 )
=-3.844/( ( 0.032 + 0.027 )/ 2 )
=-3.844/0.0295
=-13,030.51 %

where Working Capital is:

Working Capital(Q: Dec. 2021 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.024 + 0 + 0.723) - (2.213 + 0 + 1.183)
=-2.649

Working Capital(Q: Jun. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.005 + 0 + 0.791) - (2.997 + 0 + 1.658)
=-3.859

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2022) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Achiko AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2022 )
=-5.406/3.712
=-145.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Achiko AG EBIT Related Terms

Thank you for viewing the detailed overview of Achiko AG's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Achiko AG (XSWX:ACHI) Business Description

Traded in Other Exchanges
N/A
Address
Tessinerplatz 7, Zurich, CHE, CH-8002
Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.

Achiko AG (XSWX:ACHI) Headlines

No Headlines